SCHEMBL23584604

SCHEMBL23584604

CSc1ncnn2c([C@H]3CC[C@@H](CN4CC(F)(F)CC45CCN(CC(F)(F)F)CC5)O3)ccc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23584605 0.91 PRMT5 (0.30) —
SCHEMBL23584685 0.89 PRMT5 (0.31) —
SCHEMBL23584766 0.89 — —
SCHEMBL23584466 0.88 PRMT5 (0.36) —
SCHEMBL23584683 0.86 KCNH2 (0.33) —
SCHEMBL23584737 0.83 CNR2 (0.38) —
SCHEMBL23584697 0.83 — —
SCHEMBL19344260 0.83 PRMT5 (0.30) —
SCHEMBL23584601 0.79 PRMT5 (0.37) —
SCHEMBL23584603 0.78 PRMT5 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3426664-B1 SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2021-06-30 — — EP disclosed
Send feedback